Organogenesis Holdings Inc. ORGO Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Organogenesis Holdings Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s stock issuance proceeds?
- Organogenesis Holdings Inc. (ORGO) reported stock issuance proceeds of $2K in Q4 2025.
- How has Organogenesis Holdings Inc.'s stock issuance proceeds changed year-over-year?
- Organogenesis Holdings Inc.'s stock issuance proceeds decreased by 99.8% year-over-year, from $1.06M to $2K.
- What is the long-term trend for Organogenesis Holdings Inc.'s stock issuance proceeds?
- Over 4 years (2021 to 2025), Organogenesis Holdings Inc.'s stock issuance proceeds has grown at a -48.3% compound annual growth rate (CAGR), from $2.2M to $157K.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.